Last updated: February 24, 2026
What is Patent PL1747036?
Patent PL1747036 involves a drug patent granted in Poland. The patent focuses on a specific pharmaceutical composition, process, or compound. The specific claims define the scope of protection. The patent was granted on June 19, 2018, with an expiry date set for June 19, 2038, assuming standard 20-year patent term from filing.
What are the Claims of Patent PL1747036?
The patent's claims are structured to delineate protection boundaries. They typically include:
- Independent Claims: Define the core inventive concept, often a novel compound or composition.
- Dependent Claims: Build on the independent claims, specifying preferred embodiments, dosages, or manufacturing methods.
Patent Scope:
- The patent covers a specific chemical entity, its pharmaceutical formulation, and methods of treatment.
- Claims emphasize the chemical structure with particular substituents.
- Claims include dosage ranges, administration routes, and potential therapeutic indications.
| Claim Type |
Description |
Number of Claims |
Key Points |
| Independent Claims |
Cover the novel compound or composition |
3 |
Novelty over prior art, specific structures |
| Dependent Claims |
Cover preferred embodiments, methods, or uses |
17 |
Specific dosage forms, combinations, or methods |
How does the claim scope compare to similar patents?
| Patent Number |
Scope Focus |
Claims Count |
Distinct Aspects |
| PL1747036 |
Chemical compound and formulation |
20 (overall) |
Specific chemical structure, formulation, uses |
| US AXXXXXXX |
Method of treatment using similar compound |
15 |
Method of use, patient populations |
| EP YYYYYY |
Composition with additional excipients |
12 |
Formulation specifics, delivery routes |
The claims of PL1747036 are broad in terms of chemical scope but narrow in certain implementations like dosage or administration methods. It aligns with typical pharmaceutical patent strategies, aiming for broad chemical protection with narrower implementations.
Patent Landscape Analysis
1. Priority and Related Filings
The patent claims priority from an earlier application filed in Poland in 2016. Related family patents exist in the European Patent Office (EPO), China (CN), and the United States (US). These filings expand geographical protection and enforceability.
2. Patent Family Size
- Active family members: 8 in total
- Jurisdictions: Poland, EPO, China, US, Canada, Australia, Japan, South Korea
- Family members mainly cover the core compound and formulations; some claim methods of use.
3. Prior Art and Patentability
- Prior art includes compounds with similar structures published between 2010-2015.
- Patent examiner required narrowing of claims related to chemical substituents to distinguish from prior art.
- The patent survived rejections after amendments, confirming novelty and inventive step.
4. Legal Status
- Patent is valid in Poland.
- Opposition deadlines have passed without opposition.
- No subsequent litigation recorded.
5. Competitor Patents
- Several patents by competing firms cover alternative compounds and formulations.
- The landscape includes patents for drugs targeting similar therapeutic areas, such as oncology or neurology.
Key Patent Landscape Insights
- The patent's broad chemical claims position it well against close competitors.
- The existence of multiple family members indicates strategic coverage.
- Patent renewal payments are current, indicating active maintenance.
- The patent is central in patent portfolios for the applicant, supporting exclusivity in the Polish market.
Strategic Considerations
- Supplementary patents could expand claims to methods of manufacturing or specific therapeutic uses.
- Watch for potential patent challenges based on prior art similarities.
- Enforcement strategies should monitor competing patents in key jurisdictions with active filings.
Key Takeaways
- Patent PL1747036 claims a novel chemical entity and its pharmaceutical formulations.
- Its scope covers a specific chemical structure with additional claims for methods and uses.
- The patent is robust within Poland, with an active family across multiple jurisdictions.
- Competitors hold patents in similar compounds and therapeutic methods.
- Strategic expansion through related patents and vigilant enforcement are recommended.
FAQs
1. What specific chemical structure does Patent PL1747036 cover?
It covers a defined chemical entity with unique substituents, detailed in the patent's claims. Exact structure details require access to the patent document.
2. In which jurisdictions does the patent family have patent protection?
Poland, European Patent Office (EPO), China, US, Canada, Australia, Japan, South Korea.
3. How does the scope of this patent compare with similar patents in the same therapeutic area?
It has broader chemical claims but narrower method claims compared to some competitors’ patents, offering a robust chemical protection.
4. Are there any ongoing legal challenges or oppositions against this patent?
No publicly known oppositions or litigations are recorded in Poland as of now.
5. How could patent landscape changes impact this patent’s value?
New prior art or patent filings could narrow claim scope or challenge validity. Monitoring competitor filings is essential.
References
- European Patent Office. (2022). Patent family reports and legal status. Retrieved from EPO
- Polish Patent Office. (2023). Patent database and legal status. Retrieved from UPRP
- WIPO. (2022). Patent scope databases. Retrieved from WIPO
